Search

Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2) play a key role in DNA repair. As major sensors of DNA damage, they are activated to produce poly(ADP-ribose). PARP1/PARP2 inhibitors have emerged as effective drugs for the treatment of cancers with BRCA deficiencies. Here, we explored aminomethylmorpholino and aminomethylmorpholino glycine nucleosides as inhibitors of PARP1 and PARP2, using different enzymatic assays. The compounds bearing thymine or 5-Br(I)-uracil bases displayed the highest inhibition potency, with all of them being more selective toward PARP1. Interaction of the inhibitors with the NAD+ binding cavity of PARP1 (PARP2) suggested by the mixed-type inhibition was demonstrated by molecular docking and the RoseTTAFold All-Atom AI-model. The best PARP1 inhibitors characterized by the inhibition constants in the range of 12–15 µM potentiate the cytotoxicity of hydrogen peroxide by displaying strong synergism. The inhibitors revealed no impact on PARP1/PARP2 affinity for DNA, while they reduced the dissociation rate of the enzyme–DNA complex upon the autopoly(ADP-ribosyl)ation reaction, thus providing evidence that their mechanism of action for PARP trapping is due primarily to catalytic inhibition. The most active compounds were shown to retain selectivity toward PARP1, despite the reduced inhibition potency in the presence of histone PARylation factor 1 (HPF1) capable of regulating PARP1/PARP2 catalytic activity and ADP-ribosylation reaction specificity. The inhibitors obtained seem to be promising for further research as potential drugs. [ABSTRACT FROM AUTHOR]

Tyrosyl-DNA phosphodiesterases 1 and 2 (TDP1 and TDP2) are important DNA repair enzymes that remove various adducts from the 3′- and 5′-ends of DNA, respectively. The suppression of the activity of these enzymes is considered as a promising adjuvant therapy for oncological diseases in combination with topoisomerase inhibitors. The simultaneous inhibition of TDP1 and TDP2 may result in greater antitumor effects, as these enzymes can mimic each other's functions. We have previously shown that usnic acid-based sulfides can act as dual inhibitors, with TDP1 activity in the low micromolar range and their TDP2 at 1 mM. The oxidation of their sulfide moieties to sulfoxides led to an order of magnitude decrease in their cytotoxicity potential, while their TDP1 and TDP2 activity was preserved. In this work, we synthesized new series of usnic acid-based sulfides and their oxidized analogues, i.e., sulfoxides and sulfones, to systematically study these irregularities. The new compounds inhibit TDP1 with IC50 values (the concentration of inhibitor required to reduce enzyme activity by half) in the 0.33–25 μM range. Most sulfides and some sulfoxides and sulfones inhibit TDP2 with an IC50 = 138−421 μM. In addition, the most active compounds synergized (×4) with topotecan on the HeLa cell line as well as causing dose-dependent DNA damage, as confirmed by Comet assay. Sulfides with the 6-methylbenzoimidazol-2-yl substituent (8f, IC50 = 0.33/138 μM, TDP1/2) and sulfones containing a pyridine-2-yl fragment (12k, IC50 = 2/228 μM, TDP1/2) are the most potent derivatives and, therefore, are promising for further development. [ABSTRACT FROM AUTHOR]

Tourmaline is a widespread borosilicate mineral that is well known for its variable chemistry. Although a major amount of octahedral Al in tourmaline is commonplace, the occurrence of significant amounts of tetrahedral Al is relatively rare. This paper focuses on tourmaline from the collection of the A.E. Fersman Mineralogical Museum (Russia) originated from Italy with up to 25% of Si replaced by Al at the tetrahedral site. The tourmaline is characterized by optical and scanning electron microscopy, Raman spectroscopy, infrared spectroscopy, Mössbauer spectroscopy, energy-dispersive and wavelength-dispersive X-ray analysis, laser ablation inductively coupled plasma optical emission spectrometry and single-crystal X-ray diffraction. The studied tourmaline occurs as transparent dark blue crystals (with equant external morphology) up to 3 mm in size and forms veinlets cutting a (Mg,Al)-rich metamorphosed mafic-ultramafic rock (Mg >> Fe) composed of spinel, pargasite, clinochlore, phlogopite, and hydroxylapatite. The studied tourmaline meets the criteria defining magnesio-lucchesiite and can be compositionally formed via Tschermak-like ([6]Me2+ + [4]Si4+ ↔ [6]Al3+ + [4]Al3+, where [6]Me2+ = Mg,Fe) or plagioclase-like ([9]Ca2+ + [4]Al3+ ↔ [9]Na+ + [4]Si4+) substitutions. Zones with a relatively high Si content (Si-rich) have pronounced indications of dissolution, while silicon-depleted zones (Si-poor) overgrow Si-rich zones, eventually creating a visible replacement zone of the crystal. We suggest that Si-poor tourmaline results from the Si-rich tourmaline losing Si during a metasomatic process. The resulting empirical crystal-chemical formula for the Si-poor zone is: X     C a   0.95     N a   0.03     ◻ 0.02         Σ 1.00     Y     M g   1.08     A l   0.98     F e   0.50   2 +     F e   0.43   3 +         Σ 3.00     Z     A l   5.91     F e   0.09   3 +         Σ 6.00     T     S i   4.57     A l   1.43         Σ 6.00     O   18           (BO3)3V(OH)3W[O0.95(OH)0.05]Σ1.00 [a = 15.9811(2), c = 7.12520(10) Å, R1 = 1.7%] and for the Si-rich zone is: X     C a   0.89     N a   0.11         Σ 1.00     Y     M g   1.55     A l   0.80     F e   0.34   2 +     F e   0.31   3 +         Σ 3.00     Z     A l   5.51     M g   0.44     F e   0.05   3 +         Σ 6.00     T     S i   5.35     A l   0.65         Σ 6.00     O   18           (BO3)3V(OH)3W[O0.93(OH)0.07]Σ1.00 [a = 15.9621(3), c = 7.14110(10) Å, R1 = 1.7%]. According to pressure-temperature (P-T) calculations of mineral assemblage stability and comparable data on synthetic [4]Al-rich tourmalines, the studied tourmaline was formed at 600–750 °C and 0.10–0.20 GPa. The formation of tetrahedral Al-rich tourmalines requires several unusual factors: (1) desilication of primary rocks and (2) high temperatures and relatively low pressures. [ABSTRACT FROM AUTHOR]

The harsh inflammatory environment associated with injured and arthritic joints represents a major challenge to articular cartilage repair. In this study, we report the effect of cerium oxide nanoparticles, or nanoceria, in modulating development of engineered cartilage and in combating the deleterious effects of interleukin-1α. Nanoceria was found to be biocompatible with bovine chondrocytes up to a concentration of 1000 μg/mL (60,000 cells/μg of nanoceria), and its presence significantly improved compressive mechanical properties and biochemical composition (i.e., glycosaminoglycans) of engineered cartilage. Raman microspectroscopy revealed that individual chondrocytes with internalized nanoceria have increased concentrations of proline, procollagen, and glycogen as compared with cells without the nanoparticles in their vicinity. The inflammatory response due to physiologically relevant quantities of interluekin-1α (0.5 ng/mL) is partially inhibited by nanoceria. To the best of the authors' knowledge, these results are the first to demonstrate a high potential for nanoceria to improve articular cartilage tissue properties and for their long-term treatment against an inflammatory reaction.

Crystalline calcium carbonates (CCCs) are among the most widespread minerals on the Earth's surface and play a crucial role in the global carbon cycle, heavy metal sorption and incorporation. Among the numerous factors that influence the precipitation of CCCs from solution, the most determinant are the presence of additives in the mineral-forming medium, temperature, and crystallization time (aging time). The current work fills the gaps in the study of calcium carbonate crystallization from heavy metal (Me2+ = Co, Ni, Cu Fe)-containing solutions (Me2+/Ca 0.005–1.600) at different temperatures (3 and 23 °C) and aging times (21–158 days). The resulting precipitates were studied using optical and scanning electron microscopy, powder X-ray diffraction and energy-dispersive X-ray spectroscopy. Three crystalline calcium carbonates (synthetic analogues of calcite, aragonite and monohydrocalcite), as well as amorphous carbonate (AC), were found in the resulting precipitates. Temperature and aging time have a considerable effect on the phase composition, morphology and heavy metal content in CCCs. Low temperature (3 °C) and short aging times are generally favorable for the formation of monohydrocalcite and amorphous carbonate, while calcite tends to form at a higher temperature (23 °C) and in long-term experiments. Heavy metals can be incorporated into the calcite/monohydrocalcite crystal lattice in sufficient amounts, while aragonite can host a very small amount of Me2+ (or none). Calcite can concentrate Co (up to ~0.25 atoms per formula unit (apfu)) and Ni/Cu (up to ~0.05 apfu), while its Fe content is very close to the detection limits. Calcite precipitated at a higher Me2+/Ca ratio and temperature (23 °C) contains less Me2+ compared to calcite precipitated at a lower Me2+/Ca ratio and temperature (3 °C). Monohydrocalcite can host up to ~0.1 apfu of Co/Ni/Cu with no detectable preference for Me2+. The amount of Me2+ in monohydrocalcite decreases as aging time or temperature increases. It is worth noting that AC is the main carrier of heavy metals in the system being investigated and it should be considered the main host phase in heavy metal adsorption from aqueous solutions. The results obtained can be used to solve environmental issues and in mineral resource management. [ABSTRACT FROM AUTHOR]

The use of cancer chemotherapy sensitizers is a promising approach to induce the effect of clinically used anticancer treatments. One of the interesting targets is Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), a DNA-repair enzyme, that may prevent the action of clinical Topoisomerase 1 (Top1) inhibitors, such as topotecan (Tpc). Tdp1 eliminates covalent Top1-DNA (Top1c) complexes that appear under the action of topotecan and determines the cytotoxic effect of this drug. We hypothesize that Tdp1 inhibition would sensitize cells towards the effect of Tpc. Herein, we report the synthesis and study of lipophilic derivatives of purine nucleosides that efficiently suppress Tdp1 activity, with IC50 values in the 0.3–22.0 μM range. We also showed that this compound class can enhance DNA damage induced by topotecan in vitro by Comet assay on human cell lines HeLa and potentiate the antitumor effect of topotecan in vivo on a mice ascitic Krebs-2 carcinoma model. Thereby, this type of compound may be useful to develop drugs, that sensitize the effect of topotecan and reduce the required dose and, as a result, side effects. [ABSTRACT FROM AUTHOR]